Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Feb 21;163(1):167–176. doi: 10.1007/s10549-017-4158-z

Table 3.

Relationship of Patient, Oncologist, and Practice Group Variables to the Probability of Having the Multigene Test, Relative to a Standard Reference Patient with Other Variables Held Constant

Variable Variable Valuea Probability of multigene testing, % Difference in probability between the variable lowest- to highest-risk value
Age (years) 70+ 9% 51%
60–70 38%
40–50 60%
Race/ethnicity Black 28% 11%
Asian 38%
White, non-Hispanic 39%
Tumor size >0.5 cm to <=1.0 cm 15% 26%
>2.0 cm 38%
>1.0 cm to <=2.0 41%
Charlson comorbidity score 3 33% 8%
1 38%
0 41%
Community-level median family incomeb 64,000 36% 5%
87,000 38%
113,000 41%
Oncologist gender Male 38% 12%
Female 50%
Practice group oncology chief’s proportion of patients getting tested 20% 30% 14%
40% 38%
53% 44%
a

Values in bold represent the characteristics of the standard patient, who has an estimated probability of testing of 38% using the fitted multilevel regression model. Each probability estimate represents the effect of changing the value of a single variable while the other values in bold were held constant. Variable values were chosen to illustrate maximum range from lowest to highest probability of testing.

b

Community-level is from census block group characteristics.